Patents by Inventor Lennart Meurling

Lennart Meurling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified hydroxypolymer conjugates with killing effect on tumor cells
    Patent number: 8106185
    Abstract: The present invention is related to a modified hydroxypolymer conjugates preferably a guanidine-dextran conjugate having a tumor cell killing activity. The modified hydroxypolymer conjugate is used as medicine, particularly for manufacturing a medicine or tumor killing composition for treating tumors. A method for producing said hydroxypolymer conjugate and a method for killing cancer cells and treating tumors is also disclosed. The invention is also related to a method for killing tumor cells and treating tumors by administering an effective amount of the modified hydroxypolymer conjugate.
    Type: Grant
    Filed: March 6, 2008
    Date of Patent: January 31, 2012
    Assignee: Dextech Medical AB
    Inventors: Anders Holmberg, Lennart Meurling
  • MODIFIED HYDROXYPOLYMER CONJUGATES WITH KILLING EFFECT ON TUMOR CELLS
    Publication number: 20080221066
    Abstract: The present invention is related to a modified hydroxypolymer conjugates preferably a guanidine-dextran conjugate having a tumor cell killing activity. The modified hydroxypolymer conjugate is used as medicine, particularly for manufacturing a medicine or tumor killing composition for treating tumors. A method for producing said hydroxypolymer conjugate and a method for killing cancer cells and treating tumors is also disclosed. The invention is also related to a method for killing tumor cells and treating tumors by administering an effective amount of the modified hydroxypolymer conjugate.
    Type: Application
    Filed: March 6, 2008
    Publication date: September 11, 2008
    Applicant: Dextech Medical AB
    Inventors: Anders Holmberg, Lennart Meurling